Stryker Q2 2024: Net Sales and Earnings Up, Adjusted Metrics Enhanced

Details

The reported operating income margin was 19.4%, and adjusted operating income margin increased to 24.6%. Reported earnings per share (EPS) increased by 10.9% to $2.14, while adjusted EPS increased by 10.6% to $2.81. The company expects full-year 2024 organic net sales growth in the range of 9.0% to 10.0%. Stryker provided financial statements and press release as Exhibit 99.1.

Items reported

Exhibits (1)

About Stryker Corporation

Stryker Corporation is a prominent player in the medical technology industry, known for its innovative solutions across healthcare sectors such as orthopedics, medical and surgical, and neurotechnology and spine. The company's purpose is to enhance patient care through its wide array of products, including surgical equipment and advanced medical devices. Stryker plays a critical role in the healthcare market by providing essential tools and technologies that assist in improving surgical precision and patient recovery processes. With a continuous focus on research and development, Stryker Corporation remains at the forefront of medical advancements, directly impacting hospitals, surgical centers, and healthcare providers globally. The company's extensive distribution network and partnerships with medical professionals ensure that its technologies contribute to improving health outcomes across diverse geographical regions.